Half-year report · Q2

Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥1.14T2025-01-01 → 2025-06-30Cons.Revenue IFRS
Revenue¥2.34T2024-01-01 → 2024-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.10T2024-01-01 → 2024-06-30Cons.Revenue IFRS
Operating income¥68.7bn2025-01-01 → 2025-06-30Cons.Operating profit loss IFRS
Operating income¥80.9bn2024-01-01 → 2024-06-30Cons.Operating profit loss IFRS
Profit before tax¥83.8bn2025-01-01 → 2025-06-30Cons.Profit loss before tax IFRS
Profit before tax¥139.7bn2024-01-01 → 2024-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥108.5bn2024-01-01 → 2024-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥52.8bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥58.2bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥57.2bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥60.5bn2025-01-01 → 2025-06-30Cons.Profit loss IFRS
Net income¥74.2bn2024-01-01 → 2024-06-30Cons.Profit loss IFRS
Total assets¥3.30Tat 2025-06-30Cons.Assets IFRS
Total assets¥3.35Tat 2024-12-31Cons.Assets IFRS
Total assets¥3.13Tat 2024-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥1.89Tat 2025-06-30Cons.Liabilities IFRS
Total liabilities¥1.82Tat 2024-12-31Cons.Liabilities IFRS
Net assets / equity¥1.41Tat 2025-06-30Cons.Equity IFRS
Net assets / equity¥1.53Tat 2024-12-31Cons.Equity IFRS
Net assets / equity¥1.59Tat 2024-06-30Cons.Equity IFRS
Net assets / equity¥1.43Tat 2023-12-31vCons.Equity IFRS
Equity (owners)¥1.12Tat 2025-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.18Tat 2024-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.29Tat 2024-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥132.4bnat 2025-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥118.6bnat 2024-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥138.4bnat 2024-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥131.4bnat 2023-12-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥67.3bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥242.8bn2024-01-01 → 2024-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥108.7bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥61.6bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥329.4bn2024-01-01 → 2024-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥116.0bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥35.8bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥58.1bn2024-01-01 → 2024-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥21.6bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥65.232025-01-01 → 2025-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥71.872024-01-01 → 2024-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥70.652024-01-01 → 2024-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥65.222025-01-01 → 2025-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥71.862024-01-01 → 2024-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥70.652024-01-01 → 2024-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio34.0%at 2025-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio35.2%at 2024-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio41.2%at 2024-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥47.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥14.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥32.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥591m
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥38.3bn
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥38.3bn
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥30.0bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue2025-01-01 → 2025-06-30¥493.8bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2025-01-01 → 2025-06-30¥492.6bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥1.2bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2025-01-01 → 2025-06-30¥53.2bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue2025-01-01 → 2025-06-30¥129.7bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue external2025-01-01 → 2025-06-30¥127.2bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥2.5bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentsegment profit2025-01-01 → 2025-06-30¥8.6bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2025-01-01 → 2025-06-30¥273.4bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2025-01-01 → 2025-06-30¥271.8bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥1.6bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2025-01-01 → 2025-06-30¥29.5bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue2025-01-01 → 2025-06-30¥230.7bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue external2025-01-01 → 2025-06-30¥230.5bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥156m
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥33.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-06-30¥45.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-06-30¥10.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-06-30¥34.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥331m
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30−¥38.5bn
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30−¥38.5bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥26.5bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-06-30¥513.7bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-06-30¥512.5bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.2bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-06-30¥50.3bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue2024-01-01 → 2024-06-30¥71.1bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue external2024-01-01 → 2024-06-30¥69.6bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.6bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentsegment profit2024-01-01 → 2024-06-30−¥1.6bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-06-30¥271.5bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-06-30¥270.0bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.5bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-06-30¥30.1bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-06-30¥233.0bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-06-30¥232.8bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥132m
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥41.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 858
ItemContextValueUnit
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)日本マスタートラスト信託銀行株式会社(信託口)
Address major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)港区赤坂1丁目8番1号 赤坂インターシティAIR
Name major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)株式会社日本カストディ銀行(信託口)
Address major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)中央区晴海1丁目8番12号
Name major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)明治安田生命保険相互会社(常任代理人 株式会社日本カストディ銀行)
Address major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)千代田区丸の内2丁目1番1号(中央区晴海1丁目8番12号)
Name major shareholdersCurrentQuarterInstant_No4MajorShareholdersMemberText · Plus
Address major shareholdersCurrentQuarterInstant_No4MajorShareholdersMemberText · Plus
Name major shareholdersCurrentQuarterInstant_No5MajorShareholdersMemberText · Plus
Address major shareholdersCurrentQuarterInstant_No5MajorShareholdersMemberText · Plus
Name major shareholdersCurrentQuarterInstant_No6MajorShareholdersMemberText · Plus
Address major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)2-2-2 OTEMACHI, CHIYODA-KU, TOKYO, JAPAN(新宿区新宿6丁目27番30号)
Name major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)SMBC日興証券株式会社
Address major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)千代田区丸の内3丁目3番1号
Name major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)日本証券金融株式会社
Address major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)中央区日本橋茅場町1丁目2番10号
Name major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)株式会社日本カストディ銀行(信託口4)
Address major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)中央区晴海1丁目8番12号
Name major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)JPモルガン証券株式会社
Address major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)千代田区丸の内2丁目7番3号 東京ビルディング
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember
Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式(単元株式数は100株)
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember
Original text (Japanese)同上
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember-
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)キリンホールディングス株式会社
Address of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)東京都中野区中野四丁目10番2号
Information about officers (text)FilingDateInstantText · Plus
Description of fact that consolidated financial statements have been prepared in accordance with IFRS financial informationCurrentYTDDurationText · Plus
Type1 semi annual consolidated financial statements financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Condensed quarterly consolidated statement of financial position IFRS (text)CurrentYTDDurationText · Plus
Condensed year to quarter end consolidated statement of profit or loss IFRS (text)CurrentYTDDurationText · Plus
Condensed year to quarter end consolidated statement of comprehensive income IFRS (text)CurrentYTDDurationText · Plus
Condensed quarterly consolidated statement of changes in equity IFRS (text)CurrentYTDDurationText · Plus
Condensed quarterly consolidated statement of cash flows IFRS (text)CurrentYTDDurationText · Plus
Notes reporting entity condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes basis of preparation condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes significant accounting policies condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes segment information condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes equity condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes revenue condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes selling general and administrative expenses condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes other operating income condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes other operating expenses condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes finance income and finance costs condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-12-31pass
balance sheet identityconsolidated 2025-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass